Particle Therapy Market Forecast To 2033 : Trends, Segmentation, Product Type, Technology And Key Players

Overview and Scope Particle therapy is a specialized cancer treatment that utilizes charged particles, such as protons or heavier ions, to deliver radiation therapy to cancerous tumors. Particle therapy mainly treats cancer by aiming for energetic ionizing particles at the tumor site. Sizing and Forecast The particle therapy market size has grown rapidly in recent years. It will grow from $1.11 billion in 2023 to $1.26 billion in 2024 at a compound annual growth rate (CAGR) of 12.9%. The growth in the historic period can be attributed to clinical research and studies, increased cancer incidence, government support and funding, industry collaboration, improvements in treatment planning. The particle therapy market size is expected to see rapid growth in the next few years. It will grow to $1.95 billion in 2028 at a compound annual growth rate (CAGR) of 11.6%. The growth in the forecast period can be attributed to increasing healthcare expenditure, emerging applications beyond cancer, rise in geriatric population, healthcare infrastructure development, ai and data analytics integration. Major trends in the forecast period include advancements in particle accelerator technology, hypofractionation techniques, proton and carbon ion combination therapy, improved patient comfort, biology-driven treatment protocols. To access more details regarding this report, visit the link: https://www.thebusinessresearchcompany.com/report/particle-therapy-global-market-report The particle therapy market covered in this report is segmented – 1) By Type: Proton Therapy, Heavy Ion Therapy 2) By System: Single-Room Systems, Multi-Room Systems 3) By Cancer Type: Pediatric Cancer, Prostate Cancer, Lung Cancer, Breast Cancer, Brain And Spinal Cord Cancer, Other Cancer Types 4) By End-User: Hospital, Academic And Research Centers North America was the largest region in the particle therapy market in 2023. Asia-Pacific is expected to be the fastest-growing region in the particle therapy market report during the forecast period. The regions covered in the particle therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. Intrigued to explore the contents? Secure your hands-on sample copy of the report: https://www.thebusinessresearchcompany.com/sample.aspx?id=12250&type=smp Major Driver Impacting Market Growth The growing prevalence of cancer is expected to propel the growth of the particle therapy market going forward. Cancer refers to a complex and diverse group of diseases characterized by the abnormal growth and proliferation of cells in the body. Particle therapy primarily treats cancer with precise and effective radiation, where positively charged particles (protons) are accelerated to high speeds and then focused on the tumor. For instance, in February 2021, according to the reports shared by John Wiley & Sons Inc., a US-based publishing company, globally, an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths occurred in 2020. Furthermore, in May 2022, according to the Centers for Disease Control and Prevention., a US-based government agency, in the US in 2020, 1.60 million new cancer cases were recorded, and 602,347 people died of cancer. 403 new cancer cases and 144 cancer-related deaths were recorded for every 100,000 people. Therefore, the growing prevalence of cancer is driving the growth of the particle therapy market. Key Industry Players Major companies operating in the particle therapy market report are Hitachi Ltd., Mitsubishi Electric Corporation, Siemens Healthineers AG, Koninklijke Philips N.V, GE Healthcare, Sumitomo Heavy Industries Ltd., Varian Medical Systems Inc., Elekta AB, Shinva Medical Instrument Co. Ltd., Toshiba Medical Systems Corporation, Brainlab AG, Accuray Incorporated, IBA Worldwide, Mevion Medical Systems Inc., Avante Health Solutions, Provision Healthcare LLC, ViewRay, Panacea Biotec Ltd., PTW Freiburg GmbH., ProNova Solutions LLC, Optivus Proton Therapy Inc., Xstrahl Inc., Protom International Inc., Danfysik AS, SAH Global LLC, Advanced Oncotherapy plc, Particle Therapy Co-Operative Group, Best Particle Therapy Inc. The particle therapy market report table of contents includes: 1. Executive Summary 2. Particle Therapy Market Characteristics 3. Particle Therapy Market Trends And Strategies 4. Particle Therapy Market - Macro Economic Scenario ........... 32. Global Particle Therapy Market Competitive Benchmarking 33. Global Particle Therapy Market Competitive Dashboard 34. Key Mergers And Acquisitions In The Particle Therapy Market 35. Particle Therapy Market Future Outlook and Potential Analysis 36. Appendix Related Reports: https://goodprnews.com/drone-camera-market-trends/ https://goodprnews.com/extended-reality-market-analysis/ https://goodprnews.com/focused-ion-beam-market-overview/ https://topprnews.com/drone-camera-marke

Share this Post to earn Money ( Upto ₹100 per 1000 Views )


Particle Therapy Market Forecast To 2033 : Trends, Segmentation, Product Type, Technology And Key Players

Overview and Scope
Particle therapy is a specialized cancer treatment that utilizes charged particles, such as protons or heavier ions, to deliver radiation therapy to cancerous tumors. Particle therapy mainly treats cancer by aiming for energetic ionizing particles at the tumor site.

Sizing and Forecast
The particle therapy market size has grown rapidly in recent years. It will grow from $1.11 billion in 2023 to $1.26 billion in 2024 at a compound annual growth rate (CAGR) of 12.9%. The growth in the historic period can be attributed to clinical research and studies, increased cancer incidence, government support and funding, industry collaboration, improvements in treatment planning.

The particle therapy market size is expected to see rapid growth in the next few years. It will grow to $1.95 billion in 2028 at a compound annual growth rate (CAGR) of 11.6%. The growth in the forecast period can be attributed to increasing healthcare expenditure, emerging applications beyond cancer, rise in geriatric population, healthcare infrastructure development, ai and data analytics integration. Major trends in the forecast period include advancements in particle accelerator technology, hypofractionation techniques, proton and carbon ion combination therapy, improved patient comfort, biology-driven treatment protocols.

To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/particle-therapy-global-market-report

The particle therapy market covered in this report is segmented –

1) By Type: Proton Therapy, Heavy Ion Therapy
2) By System: Single-Room Systems, Multi-Room Systems
3) By Cancer Type: Pediatric Cancer, Prostate Cancer, Lung Cancer, Breast Cancer, Brain And Spinal Cord Cancer, Other Cancer Types
4) By End-User: Hospital, Academic And Research Centers

North America was the largest region in the particle therapy market in 2023. Asia-Pacific is expected to be the fastest-growing region in the particle therapy market report during the forecast period. The regions covered in the particle therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12250&type=smp

Major Driver Impacting Market Growth
The growing prevalence of cancer is expected to propel the growth of the particle therapy market going forward. Cancer refers to a complex and diverse group of diseases characterized by the abnormal growth and proliferation of cells in the body. Particle therapy primarily treats cancer with precise and effective radiation, where positively charged particles (protons) are accelerated to high speeds and then focused on the tumor. For instance, in February 2021, according to the reports shared by John Wiley & Sons Inc., a US-based publishing company, globally, an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths occurred in 2020. Furthermore, in May 2022, according to the Centers for Disease Control and Prevention., a US-based government agency, in the US in 2020, 1.60 million new cancer cases were recorded, and 602,347 people died of cancer. 403 new cancer cases and 144 cancer-related deaths were recorded for every 100,000 people. Therefore, the growing prevalence of cancer is driving the growth of the particle therapy market.

Key Industry Players
Major companies operating in the particle therapy market report are Hitachi Ltd., Mitsubishi Electric Corporation, Siemens Healthineers AG, Koninklijke Philips N.V, GE Healthcare, Sumitomo Heavy Industries Ltd., Varian Medical Systems Inc., Elekta AB, Shinva Medical Instrument Co. Ltd., Toshiba Medical Systems Corporation, Brainlab AG, Accuray Incorporated, IBA Worldwide, Mevion Medical Systems Inc., Avante Health Solutions, Provision Healthcare LLC, ViewRay, Panacea Biotec Ltd., PTW Freiburg GmbH., ProNova Solutions LLC, Optivus Proton Therapy Inc., Xstrahl Inc., Protom International Inc., Danfysik AS, SAH Global LLC, Advanced Oncotherapy plc, Particle Therapy Co-Operative Group, Best Particle Therapy Inc.

The particle therapy market report table of contents includes:

1. Executive Summary

2. Particle Therapy Market Characteristics

3. Particle Therapy Market Trends And Strategies

4. Particle Therapy Market - Macro Economic Scenario

...........

32. Global Particle Therapy Market Competitive Benchmarking

33. Global Particle Therapy Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Particle Therapy Market

35. Particle Therapy Market Future Outlook and Potential Analysis

36. Appendix

Related Reports:

https://goodprnews.com/drone-camera-market-trends/

https://goodprnews.com/extended-reality-market-analysis/

https://goodprnews.com/focused-ion-beam-market-overview/

https://topprnews.com/drone-camera-market-forecast/

https://topprnews.com/extended-reality-market-outlook/

https://topprnews.com/focused-ion-beam-market-drivers/

Contact Us:

The Business Research Company

Europe: +44 207 1930 708

Asia: +91 88972 63534

Americas: +1 315 623 0293

 

Emailinfo@tbrc.info

 

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Twitter: https://twitter.com/tbrc_info

Facebook: https://www.facebook.com/TheBusinessResearchCompany

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Blog: https://blog.tbrc.info/

Healthcare Blog: https://healthcareresearchreports.com/

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model